Bio - NCH Healthcare System

Coronary Collateral Flow Velocity in Patients. Cathet Cardiovasc Diag 1995; 36: 134-142.
Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011
PUBLICATIONS – CONT’D
23. Aguirre FV, Werth D, Gudipati C, Lewen MK, Pedersen WR, Johnson WB, Hamilton W, Gibson P,
Armbruster RW, S tonner T , Flynn MS, A l-Joundi B , Chaitman B R. Clinical an d Angiographic
Outcomes Among P atients R eceiving 2 4 v s 7 2 H ours of I ntravenous H eparin F ollowing
Accelerated Dosing of Recombinant Tissue Plasminogen Activator in Acute Myocardial Infarction.
Submitted to Circulation 7/5/96.
Books and Chapters
1. Kern MJ , Flynn MS. A pproach to t he assessment o f myocardial v iability i n the c ardiac
catheterization laboratory. In Iskandrian AS, van der Wall EE (eds): "Myocardial Viability: Detection
and Clinical Relevance," Kluwer Academic Pub, The Netherlands, 1993.
2. Kern M J, Flynn MS. Clinical applications of i ntracoronary c oronary D oppler flow v elocity i n
interventional cardiology. I n White C J ( ed): "Advances i n I nterventional C ardiology: New
Technologies and Strategies for Diagnosis and Treatment," Marcel Dekker, New York, NY, 1993.
3. Deligonul U, Ro th R, Flynn MS. A rterial and v enous access. I n Kern M J ( ed): "The C ardiac
Catheterization Handbook, 2nd edition." Mosby-Year Book, St. Louis, 1994.
ABSTRACTS
1. Aguirre FV, Werth D, Gudipati CV, Pedersen W, Lewen M, Wise NK, Changlani M, Al-Joundi B,
Flynn MS, Stonner T, K ern M J, C haitman B. F actors l imiting effective heparinization following
thrombolysis for acute myocardial infarction: interim findings from the t-PA-heparin duration trial. J
Am Coll Cardiol 1993; 21:136A.
2. Aguirre F , Werth D, Gudipati R , Gibson P , P edersen W, Johnson WB, Lewen M, Hamilton W,
Al-Joundi B, Flynn MS, Armbruster R, Stonner T, Chaitman B for t-PA heparin trial investigators.
Influence of intravenous heparin d uration o n c linical o utcome of p atients r eceiving a ccelerated
weight-adjusted r t-PA for ac ute myocardial i nfarction: pr eliminary r esults o f the multicenter
randomized t-PA heparin duration trial. Circulation 1993; 88(4):I-201.
3. Kern M J, D onohue T, B ach R , Aguirre F , Caracciolo E , M echem C, Cauley M , Flynn MS,
Chaitman B. Clinical outcome of deferred angioplasty in patients based on normal translesional
pressure-flow velocity measurements. Circulation 1993; 88(4):I-204.
4. Wolford R, Wolford T , A st M, Flynn MS, J ennison S , Cauley M , Miller LW. A ngiographic
appearance of coronary arteries f rom t ransplanted he arts pr edicts c oronary f low reserve.
Circulation 1993; 88(4):I-420.
5. Aguirre FV, Werth D, Gudipati, CV, Gibson P, Pedersen W, Lewen M, Serota H, Johnson W,
Armbruster R , A l-Joundi B , Flynn MS, S tonner T, N emeth N , Kern M J, C haitman B. Op timal
duration of heparinization following thrombolytic therapy for acute myocardial infarction: interim
results of the multicenter r andomized t -PA h eparin duration s tudy. X Vth C ongress European
8